PALATINE, Ill., June 3, 2008 — Acura Pharmaceuticals, Inc. today announced receipt from the United States Patent and Trademark Office of a Notice of Allowance for a non-provisional patent application titled “Methods and Compositions for Deterring Abuse of Opioid Containing Dosage Forms”.
